Naringin Reverses High-Cholesterol Diet-Induced Vascular Dysfunction and Oxidative Stress in Rats via Regulating LOX-1 and NADPH Oxidase Subunit Expression

Biomed Res Int. 2019 Oct 24:2019:3708497. doi: 10.1155/2019/3708497. eCollection 2019.

Abstract

Hypercholesterolaemia is associated with oxidative stress and endothelial dysfunction and leads to the development of atherosclerosis. Naringin exhibits cardiovascular protective and antioxidant properties. Therefore, the aim of this study was to assess the effect of naringin administration on vascular oxidative stress and endothelial dysfunction in hypercholesterolaemic rats and to elucidate its underlying mechanism. Sprague Dawley rats were fed a diet with 1.5% cholesterol (HCD) for 8 weeks to induce hypercholesterolaemia. Naringin (100 mg/kg body weight) was orally administrated to rats during the last 4 weeks of the diet treatment. After 8 weeks, the thoracic aorta was isolated to determine vascular function and nitric oxide (NO) levels. The aortic superoxide anion (O2 -) level was detected using dihydroethidium (DHE) fluorescence staining. Protein expression of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1), nicotinamide adenine dinucleotide phosphate (NADPH) oxidase subunits, and inducible nitric oxide synthase (iNOS), as well as oxidative damage markers, was also evaluated in aortae. Naringin treatment of hypercholesterolaemic rats enhanced aortic NO levels, restored endothelium-dependent responses to acetylcholine (ACh), and reduced aortic O2 - levels. Furthermore, naringin treatment decreased LOX-1, NADPH oxidase subunits (p47phox, Nox2, and Nox4), and iNOS as well as oxidative damage markers (3-nitrotyrosine (3-NT) and 4-hydroxynonenal (4-HNE)) expression in aortic tissues from hypercholesterolaemic rats. These results demonstrate that naringin treatment improves endothelium dysfunction in hypercholesterolaemic rats, at least partially by decreasing oxidative stress via downregulation of LOX-1 and NADPH oxidase.

MeSH terms

  • Animals
  • Aorta / drug effects
  • Aorta / pathology
  • Atherosclerosis / drug therapy*
  • Atherosclerosis / etiology
  • Atherosclerosis / genetics
  • Atherosclerosis / pathology
  • Cardiotonic Agents / pharmacology*
  • Diet, High-Fat / adverse effects
  • Disease Models, Animal
  • Endothelial Cells / drug effects
  • Flavanones / pharmacology*
  • Gene Expression Regulation / drug effects
  • Humans
  • Hypercholesterolemia / complications
  • Hypercholesterolemia / drug therapy*
  • Hypercholesterolemia / genetics
  • Hypercholesterolemia / pathology
  • NADPH Oxidase 2 / genetics
  • NADPH Oxidase 4 / genetics
  • NADPH Oxidases / genetics
  • Nitric Oxide / genetics
  • Nitric Oxide Synthase Type II / genetics
  • Oxidative Stress / drug effects*
  • Rats
  • Scavenger Receptors, Class E / genetics

Substances

  • Cardiotonic Agents
  • Flavanones
  • OLR1 protein, rat
  • Scavenger Receptors, Class E
  • Nitric Oxide
  • Nitric Oxide Synthase Type II
  • Cybb protein, rat
  • NADPH Oxidase 2
  • NADPH Oxidase 4
  • NADPH Oxidases
  • Nox4 protein, rat
  • neutrophil cytosolic factor 1
  • naringin